Dynasty Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Buy
+11,125
New +$478K ﹤0.01% 250
2026
Q1
Sell
-7,303
Closed -$372K 370
2025
Q4
$372K Sell
7,303
-584
-7% -$29.9K ﹤0.01% 265
2025
Q3
$438K Buy
+7,887
New +$462K 0.01% 234
2025
Q1
Sell
-10,546
Closed -$907K 262
2024
Q4
$907K Sell
10,546
-1,214
-10% -$131K 0.02% 154
2024
Q3
$1.4M Sell
11,760
-490
-4% -$65.3K 0.04% 102
2024
Q2
$1.75M Buy
12,250
+1,010
+9% +$134K 0.05% 86
2024
Q1
$1.44M Buy
+11,240
New +$1.34M 0.05% 91

Other funds holding NVO

Dynasty Wealth Management's NVO Position: Q2 2026 in Review

Dynasty Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 11,125 shares worth $533K. The stake represents ﹤0.01% of the portfolio and ranks #250 among its holdings. This is a return to the name: Dynasty Wealth Management previously reported a position in NVO as recently as Q4 2025.

Dynasty Wealth Management first reported a position in NVO in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.75M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dynasty Wealth Management held 11,125 shares of Novo Nordisk worth $533K as of Q2 2026.
  • Novo Nordisk was a new Dynasty Wealth Management position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #250 holding.
  • Dynasty Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 7 quarters since.
  • Dynasty Wealth Management's Novo Nordisk position peaked at $1.75M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.